On March 12, the CEO and four directors made insider buys in
to Allscripts-Misys Healthcare Solutions (
). These buys came the day before Allscripts is set to present at
the Barclays Global Healthcare Conference in Miami, Fla. The
Barclays Global Healthcare Conference is an annual conference in
which healthcare corporations from around the globe come to
discuss advances in their research, new products, their history
as well as investor information.
Director Stuart Bascomb got the ball rolling on Monday morning by
purchasing 10,000 shares at $12.64 for a total of $126,400.
Bascomb now holds 28,299 shares of Allscripts. Director Randy
Thurman bought 4,000 shares at $12.73 for a total of $50,920.
Thurman now holds 22,299 shares. Director Dennis Chookaszian made
the biggest purchase of the day by purchasing 40,000 shares at
$12.53 for a total of $501,200. Chookaszian now owns 75,595
shares of MDRX. President and CEO Paul Black bought 23,625 shares
at $12.69 for at total purchase amount of $299,801. Black now
holds 576,527 shares. Lastly, Director David Stevens added 39,600
shares to his stake at $12.74 for a transaction amount of
Allscripts-Misys is a medical health information company based
out of Chicago, Ill. The company provides clinical, financial,
information solutions and other professional services that
empower hospitals, physicians and post-acute organizations in
order to achieve the best outcome possible. Allscripts
specializes in integrated clinical software applications for
hospitals and other medical clinics.
Allscripts reported its 2012 revenue of $1,463.1 million. The
company also reported a net loss for the fourth quarter was $24.3
million this is compared to the $26 million net income of 2011.
The operating cash flow for 2012 was $225 million.
"Our fourth quarter and 2012 financial results did not meet our
expectations," said Black. "With the conclusion of the strategic
alternatives process in late December, we are moving forward to
deliver on our mission to transform healthcare delivery globally.
I have been actively engaged with our clients and team members
and we have taken initial actions to focus the company on
attaining results for our clients and shareholders."
Paul Black has been the president and CEO for Allscripts-Misys
since December 2012. Black served on the board of directors for
seven months before that. He also serves as the director of
Haemonetics Corporation (
), a public medical device company. Black received his B.S.
degree from Iowa State University and his MBA from the University
Allscripts-Misys is currently owned by 10 Gurus followed by
GuruFocus. For more information on these Gurus and their trading
activities look at the
MDRX Guru Trades Page
With its stock up 5.61% this morning, Allscripts-Misys trades at
For more information on Allscripts' insider trading look at the
MDRX Insider Trade History
Allscripts-Misys Healthcare Solutions is presenting at the
Barclays Global Healthcare Conference this afternoon at 1 PM (
). If you would like to listen to Allscripts' webcast of this
presentation follow this link. The webcast will be available for
the next two weeks.About GuruFocus: GuruFocus.com tracks the
stocks picks and portfolio holdings of the world's best
investors. This value investing site offers stock screeners and
valuation tools. And publishes daily articles tracking the latest
moves of the world's best investors. GuruFocus also provides
promising stock ideas in 3 monthly newsletters sent to